IP Library Granted Patent US 12674123
Granted Patent B2
US 12674123 · App. 17/590,231 · Granted Jul 7, 2026

Method for 3D printing of vascularized tissues and organs

Inventors: Konstanze Schäfer (Berlin, DE); Andreas Salomon (Berlin, DE)
Assignee: Technische Universitat Berlin
C12M21/08A61L27/507B29C64/112B29C64/209B29C64/245B29C64/264B29C64/393B33Y10/00B33Y30/00B33Y50/02B29L2031/7532
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12674123
App. No.
17/590,231
Granted
Jul 7, 2026
Kind
B2
Abstract

The 3D printing method disclosed here for the production of vascularized tissues and organs requires a droplet printer to produce photorealistic high-resolution prints and a device for applying non-directional or directional electromagnetic waves. The process uses a new type of capillary ink that crosslinks or undergoes a layer-forming reaction only in the edge area of the ink drops. Unbound capillary ink components are removed. The resulting cavities form a capillary network with diameters of up to approx. 10 μm. Also disclosed is a novel printer table for supplying the printed tissue with medium during printing and a printer head supply unit for individually mixing the bio-inks from cell concentrate and various ink concentrates.

Claims (34)

1 . A 3D printing process for the production of tissues and organs having vascular structures by means

(a) a droplet printer for photorealistic high-resolution prints and

(b) a device for applying electromagnetic waves

comprising:

providing at least one bio-ink and one capillary ink with cells and cross-linking molecules in the droplet printer;

placing at least one drop of the bio-ink and the capillary ink on one reaction plane;

bringing the electromagnetic waves into contact with the crosslinking molecules in these drops at the reaction level; and

activating of the cross-linking molecules by means of non-directional or directed movements of the electromagnetic waves in the drops, whereby cross-linked structures are formed and vascular structures are thus obtained; and

wherein the capillary inks crosslink or form a layer only in the edge area of the drop at a border to drops of the bio-ink

such that a cavity for the vascular structures is formed,

wherein the crosslinking or layer-forming reactions in the edge area of capillary ink droplets are caused by components in the inks without requiring an addition of a selective factor during printing,

wherein the capillary ink comprises endothelial cells and at least one of crosslinkable molecules, layer forming molecules, or a combination thereof, and

wherein after a cross-linked structure or layer structures have reached a certain height cross-linking molecules, unbound molecules and cells that are non-crosslinked or unbound are eliminated in recurring cycles.

2 . The method according to claim 1 ,

characterized in that

the drop size is between 1 fl (femtoliter) and 1 μl (microliter).

3 . The method according to claim 1 ,

characterized in that

reactions in the edge area of the capillary inks are caused by: thiolene reactions, cycloadditions, nucleophilic ring openings, self-assembly of molecules and particles, or selective factors on the cells of the capillary inks and/or bioinks.

4 . The method according to claim 1 ,

characterized in that

the bioinks include molecules that support the physiology of the printed tissue or organ.

5 . The method according to claim 1 ,

characterized in that

the bioinks contain growth factors, transcription factors, signaling molecules, marker molecules and/or target molecules for later key-lock reactions.

6 . The method according to claim 1 ,

characterized in that

culture medium or blood flows through the printed vascular structures during printing.

7 . The method according to claim 1 ,

characterized in that

the reaction plane is positioned in a bioreactor, which is connected to a blood circuit, during or after the end of a pressure of the blood circuit.

8 . The method according to claim 1 ,

characterized in that

the device for applying the electromagnetic waves is a UV lamp, a diode, a screen or a laser beam device.